The DESappear Study: Drug Eluting Scaffold (DESappear)
This study is currently recruiting participants.
Trial website: https://clinicaltrials.gov/ct2/show/NCT02869087
Trial purpose: The aim of this study is to prospectively collect information to evaluate the safety and performance of the Akesys Prava Sirolimus Eluting Bioresorbable Peripheral scaffold system for the treatment of symptomatic primary atherosclerotic stenoses and occlusions of the superficial femoral artery (SFA).